Pages that link to "Q39667297"

The following pages link to Biological reprogramming in acquired resistance to endocrine therapy of breast cancer. (Q39667297):

Displaying 35 items.

• Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate (Q24273274) (← links)
• The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set. (Q30978083) (← links)
• Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer (Q33585930) (← links)
• VAV3 mediates resistance to breast cancer endocrine therapy. (Q33827037) (← links)
• Evolutionary strategy for systemic therapy of metastatic breast cancer: balancing response with suppression of resistance (Q34650211) (← links)
• Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies (Q35016088) (← links)
• Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer (Q35200153) (← links)
• A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation. (Q35574894) (← links)
• The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer. (Q35684410) (← links)
• Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statistic (Q36105793) (← links)
• Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells (Q36400882) (← links)
• Identifying protein interaction subnetworks by a bagging Markov random field-based method. (Q36559266) (← links)
• Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer (Q36782224) (← links)
• The interaction between ER and NFκB in resistance to endocrine therapy. (Q36924406) (← links)
• Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis (Q37214212) (← links)
• Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells. (Q37687555) (← links)
• Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: Where are we now and where are we going? (Q38001839) (← links)
• Endocrine resistance in breast cancer (Q38163573) (← links)
• Understanding tamoxifen adherence in women with breast cancer: A qualitative study. (Q38399176) (← links)
• Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibit (Q39172020) (← links)
• Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer (Q39185424) (← links)
• Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells (Q39321624) (← links)
• Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolome. (Q39566899) (← links)
• Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells (Q41134570) (← links)
• More than just side-effects: The role of clinical and psychosocial factors in non-adherence to tamoxifen. (Q47681960) (← links)
• UBASH3B promotes tamoxifen resistance and could be negatively regulated by ESR1. (Q52680490) (← links)
• Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family. (Q54570256) (← links)
• The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer (Q57112955) (← links)
• The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer (Q57288786) (← links)
• Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA (Q57472758) (← links)
• TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells (Q58777990) (← links)
• Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours (Q60919172) (← links)
• alterations and metastasis in estrogen receptor positive breast cancer (Q64067053) (← links)
• Nucleosome destabilization by nuclear non-coding RNAs (Q89665043) (← links)
• The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis (Q92797016) (← links)